Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma

BACKGROUND. Conflicting data exist regarding the prognostic impact of the isocitrate dehydrogenase (IDH) mutation in intrahepatic cholangiocarcinoma (ICC), and limited data exist in patients with advanced-stage disease. Similarly, the clinical phenotype of patients with advanced IDH mutant (IDHm) IC...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Goyal, Lipika, Govindan, Aparna, Sheth, Rahul A., Nardi, Valentina, Blaszkowsky, Lawrence S., Faris, Jason E., Clark, Jeffrey W., Ryan, David P., Kwak, Eunice L., Allen, Jill N., Murphy, Janet E., Saha, Supriya K., Hong, Theodore S., Wo, Jennifer Y., Ferrone, Cristina R., Tanabe, Kenneth K., Chong, Dawn Q., Deshpande, Vikram, Borger, Darrell R., Iafrate, A. John, Bardeesy, Nabeel, Zheng, Hui, Zhu, Andrew X.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2015
Soggetti:
Gastrointestinal Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4571807/
https://ncbi.nlm.nih.gov/pubmed/26245674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0210
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi